ID   IRF1_RAT                Reviewed;         328 AA.
AC   P23570;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   24-JUL-2024, entry version 150.
DE   RecName: Full=Interferon regulatory factor 1;
DE            Short=IRF-1;
GN   Name=Irf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2342469; DOI=10.1128/mcb.10.6.3087-3094.1990;
RA   Yu-Lee L.Y., Hrachovy J.A., Stevens A.M., Schwarz L.A.;
RT   "Interferon-regulatory factor 1 is an immediate-early gene under
RT   transcriptional regulation by prolactin in Nb2 T cells.";
RL   Mol. Cell. Biol. 10:3087-3094(1990).
CC   -!- FUNCTION: Transcriptional regulator which displays a remarkable
CC       functional diversity in the regulation of cellular responses (By
CC       similarity). Regulates transcription of IFN and IFN-inducible genes,
CC       host response to viral and bacterial infections, regulation of many
CC       genes expressed during hematopoiesis, inflammation, immune responses
CC       and cell proliferation and differentiation, regulation of the cell
CC       cycle and induction of growth arrest and programmed cell death
CC       following DNA damage (By similarity). Stimulates both innate and
CC       acquired immune responses through the activation of specific target
CC       genes and can act as a transcriptional activator and repressor
CC       regulating target genes by binding to an interferon-stimulated response
CC       element (ISRE) in their promoters (By similarity). Has an essentail
CC       role in IFNG-dependent immunity to mycobacteria (By similarity). Binds
CC       to a consensus sequence in gene promoters (By similarity). Its target
CC       genes for transcriptional activation activity include: genes involved
CC       in anti-viral response, such as IFN-alpha/beta, RIGI, TNFSF10/TRAIL,
CC       ZBP1, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial
CC       response, such as GBP2, GBP5 and NOS2/INOS; anti-proliferative
CC       response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as
CC       BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7,
CC       IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA
CC       repair, such as POLQ/POLH; MHC class I expression, such as TAP1,
CC       PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II
CC       expression, such as CIITA; metabolic enzymes, such as ACOD1/IRG1 (By
CC       similarity). Represses genes involved in anti-proliferative response,
CC       such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune
CC       response, such as FOXP3, IL4, ANXA2 and TLR4 (By similarity).
CC       Stimulates p53/TP53-dependent transcription through enhanced
CC       recruitment of EP300 leading to increased acetylation of p53/TP53 (By
CC       similarity). Plays an important role in immune response directly
CC       affecting NK maturation and activity, macrophage production of IL12,
CC       Th1 development and maturation of CD8+ T-cells (By similarity). Also
CC       implicated in the differentiation and maturation of dendritic cells and
CC       in the suppression of regulatory T (Treg) cells development (By
CC       similarity). Acts as a tumor suppressor and plays a role not only in
CC       antagonism of tumor cell growth but also in stimulating an immune
CC       response against tumor cells (By similarity).
CC       {ECO:0000250|UniProtKB:P10914, ECO:0000250|UniProtKB:P15314}.
CC   -!- ACTIVITY REGULATION: Activated by MYD88.
CC       {ECO:0000250|UniProtKB:P15314}.
CC   -!- SUBUNIT: Monomer (By similarity). Homodimer (By similarity). Interacts
CC       with EP300 (By similarity). Interacts with MYD88 (By similarity).
CC       Interacts with PIAS3 (By similarity). Interacts with SPOP (By
CC       similarity). {ECO:0000250|UniProtKB:P10914,
CC       ECO:0000250|UniProtKB:P15314}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P15314}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P15314}. Note=MYD88-associated IRF1 migrates
CC       into the nucleus more efficiently than non-MYD88-associated IRF1.
CC       {ECO:0000250|UniProtKB:P15314}.
CC   -!- PTM: Phosphorylated by CK2 and this positively regulates its activity.
CC       {ECO:0000250|UniProtKB:P10914}.
CC   -!- PTM: Sumoylation represses the transcriptional activity and displays
CC       enhanced resistance to protein degradation (By similarity). Sumolyated
CC       by UBE2I/UBC9 and SUMO1 (By similarity). Inactivates the tumor
CC       suppressor activity (By similarity). Elevated levels in tumor cells (By
CC       similarity). Major site is Lys-276 (By similarity). Sumoylation is
CC       enhanced by PIAS3 (By similarity). Desumoylated by SENP1 in tumor cells
CC       and appears to compete with ubiquitination on C-terminal sites (By
CC       similarity). {ECO:0000250|UniProtKB:P10914,
CC       ECO:0000250|UniProtKB:P15314}.
CC   -!- PTM: Ubiquitinated in a SPOP-depedent manner. Appears to compete with
CC       sumoylation on C-terminal sites (By similarity).
CC       {ECO:0000250|UniProtKB:P10914}.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00840}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M34253; AAA41450.1; -; mRNA.
DR   PIR; A36330; A36330.
DR   RefSeq; NP_036723.1; NM_012591.1.
DR   AlphaFoldDB; P23570; -.
DR   SMR; P23570; -.
DR   STRING; 10116.ENSRNOP00000010968; -.
DR   ChEMBL; CHEMBL5927; -.
DR   PhosphoSitePlus; P23570; -.
DR   PaxDb; 10116-ENSRNOP00000010968; -.
DR   GeneID; 24508; -.
DR   KEGG; rno:24508; -.
DR   UCSC; RGD:2920; rat.
DR   AGR; RGD:2920; -.
DR   CTD; 3659; -.
DR   RGD; 2920; Irf1.
DR   eggNOG; ENOG502QVVN; Eukaryota.
DR   InParanoid; P23570; -.
DR   OrthoDB; 3740806at2759; -.
DR   PhylomeDB; P23570; -.
DR   PRO; PR:P23570; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; IMP:RGD.
DR   GO; GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; ISO:RGD.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; IEP:RGD.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IDA:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0002376; P:immune system process; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0042532; P:negative regulation of tyrosine phosphorylation of STAT protein; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISS:UniProtKB.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB.
DR   GO; GO:2000564; P:regulation of CD8-positive, alpha-beta T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; NAS:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0034124; P:regulation of MyD88-dependent toll-like receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0060416; P:response to growth hormone; IDA:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060333; P:type II interferon-mediated signaling pathway; ISS:UniProtKB.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR017431; IRF1/IRF2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; INTERFERON REGULATORY FACTOR; 1.
DR   PANTHER; PTHR11949:SF3; INTERFERON REGULATORY FACTOR 1; 1.
DR   Pfam; PF00605; IRF; 1.
DR   PIRSF; PIRSF038196; IFN_RF1/2; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Antiviral defense; Cytoplasm; DNA-binding;
KW   Immunity; Innate immunity; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..328
FT                   /note="Interferon regulatory factor 1"
FT                   /id="PRO_0000154547"
FT   DNA_BIND        5..113
FT                   /note="IRF tryptophan pentad repeat"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00840"
FT   REGION          92..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        116..143
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        146..164
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         78
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P10914"
FT   CROSSLNK        276
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        300
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   328 AA;  37065 MW;  B94ADE14E975BBD9 CRC64;
     MPITRMRMRP WLEMQINSNQ IPGLSWINKE EMIFQIPWKH AALHGWDINK DACLFRSWAI
     HTGRYKAGEK EPDPKTWKAN FRCAMNSLPD IEEVKDQSRN KGSSAVRVYR MLPPLTKNQR
     KERKSKSSRD TKSKTKRKLC GDSSPDTLSD GLSSSTLPDD HSSYTAQGYL GQDLDMDRDI
     TPALSPCVVS SSLSEWHMQM DIMPDSTTDL YNLQVSPMPS TSEAATDEDE EGKLPEDIMK
     LFEQSEWQPT HVDGKGYLLN EPGAQLSTVY GDFSCKEEPE IDSPGGDIEI GIQRVFTEMK
     NMDPVMWMDT LLGNSTRPPS IQAIPCAP
//
